ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer

Clinical trial NCT06224673 · RECRUITING

Trial details

NCT number: NCT06224673
Sponsor: Laura Huppert, MD, BA
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2 Low Breast Carcinoma Triple Negative Breast Cancer Hormone-receptor-positive Breast Cancer Hormone Receptor Positive Breast Carcinoma

Start date: 2026-06-05
Primary completion: 2029-11-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.